Bio
Ruben Yiqi Luo, PhD, DABCC, FADLM is an Assistant Professor of Pathology at Stanford University and an Associate Director of Clinical Chemistry Laboratory at Stanford Health Care. He has been dedicated to innovations in laboratory medicine: discovery of novel diagnostic markers and invention of diagnostic technologies. He completed his clinical chemistry fellowship at University of California San Francisco. Prior to the fellowship, he had several years of work experience in the clinical diagnostic industry. He received his PhD in analytical chemistry from Stanford University, and BS in chemistry from Peking University.
His research focuses on (1) discovering the clinical diagnostic value of molecular characteristics of protein biomarkers, and (2) developing high-resolution mass spectrometry and label-free optical sensing technologies for accurate measurement of biomarkers. His research has led to the development of advanced technologies for in-depth characterization of proteoforms and novel analytical methods for clinical diagnostics, and resulted in over 50 research articles and multiple patents.
He stays as an active participant and conference speaker in major academic organizations, including the Association for Diagnostics and Laboratory Medicine (ADLM; formerly AACC), the Mass Spectrometry & Advances in Clinical Lab (MSACL), the American Society for Mass Spectrometry (ASMS), and the American Chemical Society (ACS). His work has been recognized with prestigious academic awards such as the 2025 MSACL Michael S. Bereman Award for Clinical Science Innovation, the 2022 AACC George Grannis Award for Excellence in Research and Scientific Publication, the 2021 NACCCA Outstanding Research Award, and the 2020 American Society for Clinical Pathology (ASCP) “40 Under Forty” Honoree. He currently serves as an associate editor of JMSACL and as an editorial board member of Scientific Reports.
